Loading the map…
Research and experimental development on biotechnology · London
Valink Therapeutics
Valink Therapeutics Ltd
Private limited company registered in London, classed under “Research and experimental development on biotechnology”.
Headline figures
FY to Dec 2025 · Company only
Turnover
For subscribers
Profit after tax
—
Not filed: small-company exemption
Net assets
For subscribers
Cash
For subscribers
Employees
For subscribers
Retained reserves
For subscribers
What the numbers say
3 findings from the figures, in plain English
Written by rules from the figures on this page. Not a forecast or a credit opinion.
History
| £ | 2021 | 2022 | 2023 | 2024* | 2025 |
|---|---|---|---|---|---|
| Profit after tax | — | ||||
| Turnover | |||||
| Net assets | |||||
| Cash | |||||
| Employees | |||||
| Retained reserves |
Every figure for all 5 years
“—” means we did not find the figure in a source; it is never filled with an estimate. * Restated: the next year's accounts printed different figures for this year, and those later figures are shown.
Balance sheet and ratios
From the filed balance sheets · £
| Balance sheet | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Fixed assets | ||||
| Current assets | ||||
| of which debtors | ||||
| of which cash | ||||
| Net current assets | ||||
| Net assets |
6 balance-sheet lines, every year
A ratio appears only for years where every line it needs was filed. Lines are as tagged in the accounts; nothing is added up or estimated.
Timeline
Checked 2026-10-25
- AccountsTotal exemption full accounts made up to 31 December 2025
- SharesStatement of capital following an allotment of shares on 5 August 2025 · GBP 103,772.57 (and 4 more like it since 28 January 2022)
- AccountsTotal exemption full accounts made up to 31 December 2024
- DirectorsTermination of appointment of Arne Hagen August Scheu as a director on 16 May 2025
- DirectorsDirector's details changed for Mr Arne Hagen August Scheu on 10 December 2024
- DirectorsDirector's details changed for Mr Irsyad Noor Abadi Bin Khairil Anuar on 10 December 2024
- AccountsTotal exemption full accounts made up to 31 December 2023
- AddressRegistered office address changed from Unit 306 Westbourne Studios 242 Acklam Road London W10 5JJ United Kingdom to Imperial Translation & Innovation Hub 84 Wood Lane London W12…
- NameCertificate of change of name
- AccountsTotal exemption full accounts made up to 31 December 2022
- OwnershipNotification of a person with significant control statement
- OwnershipCessation of Arne Hagen August Scheu as a person with significant control on 4 August 2023
12 earlier
- DirectorsDirector's details changed for Mr Arne Hagen August Scheu on 23 June 2023
- OwnershipChange of details for Mr Arne Hagen August Scheu as a person with significant control on 23 June 2023
- SharesSecond filing of a statement of capital following an allotment of shares on 31 December 2022 · GBP 15,925.31
- AccountsTotal exemption full accounts made up to 31 December 2021
- AddressRegistered office address changed from 36 Butleigh House Healum Avenue Southall Middlesex UB2 4WL United Kingdom to Unit 306 Westbourne Studios 242 Acklam Road London W10 5JJ on…
- DirectorsDirector's details changed for Irsyad Noor Abadi Bin Khairil Anuar on 1 December 2021
- OwnershipChange of details for Arne Hagen August Scheu as a person with significant control on 1 December 2021
- DirectorsDirector's details changed for Arne Hagen August Scheu on 1 December 2021
- OwnershipNotification of Arne Hagen August Scheu as a person with significant control on 18 February 2021
- OwnershipWithdrawal of a person with significant control statement on 22 February 2021
- DirectorsTermination of appointment of Sheryl Ying Ting Lim as a director on 18 February 2021
- IncorporationIncorporation
- Directors
From the Companies House filing history. Routine confirmation statements are left out, and a run of the same filing is shown once.
Questions people ask
›What does Valink Therapeutics do?
Private limited company registered in London, classed under “Research and experimental development on biotechnology”.
›How much turnover does Valink Therapeutics make?
Answered in the full report
›Is Valink Therapeutics profitable?
Valink Therapeutics's profit isn't public: small companies may file without a profit and loss account.
›How many people work at Valink Therapeutics?
Answered in the full report
›Who runs and owns Valink Therapeutics?
Its directors are Irsyad Noor Abadi Bin Khairil Anuar. Its owners are shown to subscribers.
›Where is Valink Therapeutics based?
Its registered office is Imperial Translation & Innovation Hub, 84 Wood Lane, London, W12 0BZ., in London.
›When was Valink Therapeutics founded?
Valink Therapeutics Ltd was incorporated on 11 December 2020.
›Is Valink Therapeutics still trading?
The register lists Valink Therapeutics Ltd as active.